Erratum: Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (European Journal of Clinical Microbiology and Infectious Diseases DOI: 10.1007/s10096-012-1737-0);Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 2, 2013, Pages 253-259

  Miro E ^a   Aguero J ^b,c   Larrosa, M N ^d,j   Fernandez A ^e   Conejo, M C ^f   Bou, G ^e   Gonzalez Lopez J J ^d,j   Lara, N ^g   Martinez Martinez L ^b,c   Oliver, A ^h   Aracil, B ^g   Oteo, J ^g   Pascual, A ^f,i   Rodriguez Bano J ⁱ   Zamorano, L ^h   Navarro, F ^a,j  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL JUAN CANALEJO   (Spain)

^f UNIVERSITY OF SEVILLE   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL ENZYME; BETA LACTAMASE AMPC; CARBAPENEMASE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PROTEIN CMY 2; PROTEIN DHA 1; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLA GENE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; SEQUENCE ANALYSIS; SPAIN;

EID: 84872600286     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1756-x     Document Type: Erratum

References (39)

1. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153-2162
2. Mata C, Miró E, Rivera A et al (2010) Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 16:472-476
3. Navarro F, Pérez-Trallero E, Marimón JM et al (2001) CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 48:383-389
4. Yamasaki K, Komatsu M, Abe N et al (2010) Laboratory surveillance for prospective plasmid-mediated AmpC β-lactamases in the Kinki region of Japan. J Clin Microbiol 48:3267-3273
5. Song W, Kim JS, Kim HS et al (2006) Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 55:219-224
6. Empel J, Baraniak A, Literacka E et al (2008) Molecular survey of β-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 52:2449-2454
7. CTX-M genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. J Antimicrob Chemother 65:661-665
8. Oteo J, Hernández-Almaraz JL, Gil-Antón J et al (2010) Outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J 29:1144-1146
9. IMP-8, associated with OXY hyperproduction, in the intensive care unit of a community hospital in Spain. J Antimicrob Chemother 65:1071-1073
10. Giakoupi P, Maltezou H, Polemis M et al; Greek System for the Surveillance of Antimicrobial Resistance (2009) KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 14. pii: 19218
11. Cuzon G, Ouanich J, Gondret R et al (2011) Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 55:2420-2423
12. Struelens MJ, Monnet DL, Magiorakos AP et al; European NDM-1 Survey Participants (2010) New Delhi metallo-β-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 15. pii: 19716
13. Miriagou V, Cornaglia G, Edelstein M et al (2010) Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 16:112-22
14. Navarro F, Calvo J, Cantón R et al (2011) Detection of resistance phenotypes in gram-negative bacteria. Enferm Infecc Microbiol Clin 29:524-534
15. Walther-Rasmussen J, Høiby N (2007) Class A carbapenemases. J Antimicrob Chemother 60:470-482
16. Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement, M100-S14. CLSI, Wayne, PA, USA
17. Pasteran F, Mendez T, Guerriero L et al (2009) Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 47:1631-1639
18. GES-1 and a fused product of aac(3)-Ib/aac(6″)-Ib" gene cassettes in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46:638-645
19. Yigit H, Queenan AM, Anderson GJ et al (2001) Novel carbapenem- hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161
20. SPM-1-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob Agents Chemother 48:1406-1409
21. VIM-2 carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob Agents Chemother 45:546-552
22. Rodríguez-Baño J, Miró E, Villar M et al (2012) Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases. J Infect 64:176-183
23. Oteo J, Navarro C, Cercenado E et al (2006) Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44:2359-2366
24. Sabbuba NA, Mahenthiralingam E, Stickler DJ (2003) Molecular epidemiology of Proteus mirabilis infections of the catheterized urinary tract. J Clin Microbiol 41:4961-4965
25. Tenover FC, Arbeit RD, Goering RV et al (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239
26. Ding H, Yang Y, Lu Q et al (2008) The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur J Clin Microbiol Infect Dis 27:915-921
27. Queenan AM, Bush K (2007) Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20:440-458
28. Tórtola MT, Lavilla S, Miró E et al (2005) First detection of a carbapenem-hydrolyzing metalloenzyme in two Enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother 49:3492-3494
29. Tato M, Coque TM, Ruíz-Garbajosa P et al (2007) Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-β-lactamase in Spain: toward endemicity? Clin Infect Dis 45:1171-1178
30. Pérez-Llarena FJ, Fernández A, Zamorano L et al (2012) Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate. Antimicrob Agents Chemother 56:4540-4543
31. Gaibani P, Ambretti S, Berlingeri A et al (2011) Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large italian hospital: surveillance period 1 March-30 September 2010. Euro Surveill 16. pii: 19800
32. Solé M, Pitart C, Roca I et al (2011) First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother 55:4402-4404
33. Pitart C, Solé M, Roca I et al (2011) First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 55:4398-4401
34. Oteo J, Cercenado E, Cuevas O et al (2010) AmpC β-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131. Diagn Microbiol Infect Dis 67:270-276
35. Naseer U, Haldorsen B, Simonsen GS et al (2010) Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin Microbiol Infect 16:171-178
36. Empel J, Hrabák J, Kozińska A et al (2010) DHA-1-producing Klebsiella pneumoniae in a teaching hospital in the Czech Republic. Microb Drug Resist 16:291-295
37. Ohana S, Leflon V, Ronco E et al (2005) Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC β-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother 49:2095-2097
38. VIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother 61:59-63
39. Cagnacci S, Gualco L, Roveta S et al (2008) Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem- hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak. J Antimicrob Chemother 61:296-300